Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Grand Rounds

FDA Grand Rounds Home
          Science & Research
          About Science & Research at FDA
          FDA Grand Rounds
          Project Orbis: Global Collaborative Oncology Review Program - 05/13/2021 - 05/13/2021FDA Grand Rounds Webcast
    Event Title
              Project Orbis: Global Collaborative Oncology Review Program


                  May 13, 2021

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
           

May 13, 2021
                
  Organized By: 
      Organizer
          Office of Scientific Professional Development

 





About the Speaker:

R. Angelo de Claro, MD
Associate Director (Acting) for Global Clinical Sciences
U.S. FDA Oncology Center of Excellence

Dr. de Claro is a hematologist-oncologist with 11 years of FDA experience. He leads OCE efforts to advance cancer drug development and regulatory science across the globe, including direction of Project Orbis. He is also Director for Division of Hematologic Malignancies I, within the Office of Oncologic Diseases/Office of New Drugs/ Center for Drug Evaluation and Research (CDER).

About the Presentation:

FDA Oncology Center of Excellence (OCE) launched Project Orbis in May 2019 with international regulatory authorities as a global collaborative review program for oncology marketing applications. Current Project Orbis partners include the regulatory health authorities of Australia, Brazil, Canada, Singapore, Switzerland, and the United Kingdom. The program aims to facilitate the submission, review, and approval of high impact oncology marketing applications across the participating countries.

Learning Objectives:

Discuss the general framework of Project Orbis.
	Explain how other FDA and OCE review programs interact with Project Orbis.Webcast:

Webcast Recording





Event Materials

  Title
            File Type/SizeActivity Outline FDA Grand Rounds: May 13, 2021
              pdf               (195.02 KB)

                                                                                  Content current as of:
      04/19/2021More Meetings,
      Conferences, and
      Workshops
        
        FDA Grand Rounds
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop